JANUS HENDERSON GROUP PLC - NOVARTIS A G ownership

NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,122 filers reported holding NOVARTIS A G in Q1 2022. The put-call ratio across all filers is 0.55 and the average weighting 0.2%.

Quarter-by-quarter ownership
JANUS HENDERSON GROUP PLC ownership history of NOVARTIS A G
ValueSharesWeighting
Q3 2023$258,005,160
-1.7%
2,532,937
-2.6%
0.17%
+3.7%
Q2 2023$262,493,672
-21.0%
2,601,266
-28.0%
0.16%
-25.6%
Q1 2023$332,191,931
-6.9%
3,610,783
-8.2%
0.22%
-14.1%
Q4 2022$356,828,315
+40.4%
3,933,293
-41.1%
0.26%
+34.2%
Q3 2022$254,071,818
-5.8%
6,678,540
+109.4%
0.19%
+2.2%
Q2 2022$269,590,000
-9.1%
3,189,284
-5.7%
0.19%
+30.1%
Q1 2022$296,673,000
-4.7%
3,380,885
-5.0%
0.14%
+10.0%
Q4 2021$311,322,000
-4.5%
3,559,179
-10.7%
0.13%
-9.1%
Q3 2021$325,936,000
-15.7%
3,985,517
-6.0%
0.14%
-13.9%
Q2 2021$386,736,000
-1.2%
4,238,667
-7.5%
0.17%
-7.3%
Q1 2021$391,615,000
-11.2%
4,581,365
-1.9%
0.18%
-12.7%
Q4 2020$440,950,000
+9.3%
4,669,601
+0.6%
0.20%
-2.4%
Q3 2020$403,469,000
-1.5%
4,639,707
-1.0%
0.21%
-8.7%
Q2 2020$409,419,000
+11.4%
4,687,648
+5.1%
0.23%
-9.1%
Q1 2020$367,665,000
-19.2%
4,459,253
-7.2%
0.25%
+8.6%
Q4 2019$454,998,000
+11.5%
4,805,137
+2.3%
0.23%
+5.4%
Q3 2019$408,145,000
+14.5%
4,696,715
+20.3%
0.22%
+14.5%
Q2 2019$356,470,000
-0.3%
3,903,956
+5.0%
0.19%
-2.5%
Q1 2019$357,400,000
+24.5%
3,717,495
+11.1%
0.20%
+8.2%
Q4 2018$287,129,000
+2.0%
3,346,099
+2.4%
0.18%
+22.0%
Q3 2018$281,515,000
+47.5%
3,267,352
+29.3%
0.15%
+37.6%
Q2 2018$190,812,000
+23.6%
2,525,979
+32.2%
0.11%
+19.8%
Q1 2018$154,434,000
-19.0%
1,910,135
-15.9%
0.09%
-22.2%
Q4 2017$190,611,000
+19.1%
2,270,260
+21.8%
0.12%
+13.6%
Q3 2017$160,058,000
+0.1%
1,864,396
-2.6%
0.10%
-5.5%
Q2 2017$159,821,000
+48038.9%
1,914,516
+42797.5%
0.11%
+5350.0%
Q1 2017$332,000
+2.2%
4,4630.0%0.00%0.0%
Q4 2016$325,000
-7.7%
4,4630.0%0.00%
-33.3%
Q3 2016$352,000
+8.6%
4,463
+13.6%
0.00%0.0%
Q2 2016$324,000
+13.7%
3,9290.0%0.00%
+50.0%
Q1 2016$285,000
-95.1%
3,929
-94.1%
0.00%
-95.7%
Q4 2015$5,758,000
-6.4%
66,9290.0%0.05%
-14.8%
Q3 2015$6,152,000
-6.6%
66,929
-0.1%
0.05%
+3.8%
Q2 2015$6,590,000
+6.1%
67,022
+6.4%
0.05%
+8.3%
Q1 2015$6,213,000
+6.5%
63,0000.0%0.05%
+14.3%
Q4 2014$5,834,00063,0000.04%
Other shareholders
NOVARTIS A G shareholders Q1 2022
NameSharesValueWeighting ↓
Martin Investment Management, LLC 229,184$23,344,6827.00%
Foresight Global Investors, Inc. 97,500$9,397,7375.23%
SCHARF INVESTMENTS, LLC 1,425,745$145,226,3224.34%
MANAGED ASSET PORTFOLIOS, LLC 274,204$27,930,3694.28%
GARLAND CAPITAL MANAGEMENT INC 54,710$5,572,7613.93%
PRENTISS SMITH & CO INC 52,032$5,299,9803.91%
WILKINS INVESTMENT COUNSEL INC 130,950$13,3393.61%
First Fiduciary Investment Counsel, Inc. 145,731$14,8443.48%
Cullen Capital Management, LLC 2,714,809$276,530,4643.23%
JOHN G ULLMAN & ASSOCIATES INC 182,690$18,608,8033.04%
View complete list of NOVARTIS A G shareholders